155 related articles for article (PubMed ID: 29624558)
1. A Phase 1 Pharmacokinetic and Safety Study of Extended-Duration, High-dose Cefixime for Cephalosporin-resistant Neisseria gonorrhoeae in the Pharynx.
Barbee LA; Nayak SU; Blumer JL; OʼRiordan MA; Gray W; Zenilman JM; Golden MR; Griffiss JM
Sex Transm Dis; 2018 Oct; 45(10):677-683. PubMed ID: 29624558
[TBL] [Abstract][Full Text] [Related]
2. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
[TBL] [Abstract][Full Text] [Related]
3. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval.
Deguchi T; Yasuda M; Yokoi S; Ishida K; Ito M; Ishihara S; Minamidate K; Harada Y; Tei K; Kojima K; Tamaki M; Maeda S
J Infect Chemother; 2003 Mar; 9(1):35-9. PubMed ID: 12673405
[TBL] [Abstract][Full Text] [Related]
4. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Data Are Predictive of
Connolly KL; Eakin AE; Gomez C; Osborn BL; Unemo M; Jerse AE
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642924
[TBL] [Abstract][Full Text] [Related]
6. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
[TBL] [Abstract][Full Text] [Related]
7. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.
Gratrix J; Bergman J; Egan C; Drews SJ; Read R; Singh AE
Sex Transm Dis; 2013 Nov; 40(11):877-9. PubMed ID: 24113412
[TBL] [Abstract][Full Text] [Related]
8. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Tapsall JW
Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
[TBL] [Abstract][Full Text] [Related]
9. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.
Allen VG; Mitterni L; Seah C; Rebbapragada A; Martin IE; Lee C; Siebert H; Towns L; Melano RG; Low DE
JAMA; 2013 Jan; 309(2):163-70. PubMed ID: 23299608
[TBL] [Abstract][Full Text] [Related]
10. Treatment of uncomplicated gonorrhea with single doses of 200 mg cefixime.
Verdon MS; Douglas JM; Wiggins SD; Handsfield HH
Sex Transm Dis; 1993; 20(5):290-3. PubMed ID: 8235928
[TBL] [Abstract][Full Text] [Related]
11. Preparing for an era of untreatable gonorrhea.
Barbee LA
Curr Opin Infect Dis; 2014 Jun; 27(3):282-7. PubMed ID: 24685549
[TBL] [Abstract][Full Text] [Related]
12. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
[TBL] [Abstract][Full Text] [Related]
13. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
Singh AE; Gratrix J; Read R; Lovgren M; Drews SJ; Romanowski B; Sutherland K; Talbot J; Martin I
Sex Transm Dis; 2013 Sep; 40(9):744-50. PubMed ID: 23945428
[TBL] [Abstract][Full Text] [Related]
14. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.
Handsfield HH; McCormack WM; Hook EW; Douglas JM; Covino JM; Verdon MS; Reichart CA; Ehret JM
N Engl J Med; 1991 Nov; 325(19):1337-41. PubMed ID: 1922235
[TBL] [Abstract][Full Text] [Related]
15. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.
Singh AE; Gratrix J; Martin I; Friedman DS; Hoang L; Lester R; Metz G; Ogilvie G; Read R; Wong T
Sex Transm Dis; 2015 Jun; 42(6):331-6. PubMed ID: 25970311
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
Hook EW; Golden MR; Taylor SN; Henry E; Tseng C; Workowski KA; Swerdlow J; Nenninger A; Cammarata S
Sex Transm Dis; 2019 May; 46(5):279-286. PubMed ID: 30985632
[TBL] [Abstract][Full Text] [Related]
18. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
[TBL] [Abstract][Full Text] [Related]
19. Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group.
Hook EW; McCormack WM; Martin D; Jones RB; Bean K; Maroli AN
Antimicrob Agents Chemother; 1997 Aug; 41(8):1843-5. PubMed ID: 9257777
[TBL] [Abstract][Full Text] [Related]
20. The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime.
McMillan A; Young H
Int J STD AIDS; 2007 Apr; 18(4):253-4. PubMed ID: 17509176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
